F2G

1 follower


F2G is a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening invasive fungal infections.

Industries

Headquarters

Employees

Links

Org chart

Francesco Maria Lavino

Collapse
John H. Rex
Chief Medical Officer
Tony Kennedy
Chief Scientific & Development Officer
Janelle R. Anderson
Chief Business Officer
Mark Baglin
Chief Commercial Officer
Ana Zaccaro
Vice President Regulatory Affairs
daniela zinzi
VP, Clinical R&D
Dean Thompson
Director, Analytical Development
Mark Bresnik, MD
Executive Director, Clinical R&D
Karen Cornelissen
Director Early Clinical Development
Sufyaan Bhamjee
In-House Counsel